IN

Invitris

YC W23 ↗

Munich, DE · Founded 2022 · 6 employees · 2 known investors

invitris.com ↗

Invitris develops cell-free protein synthesis platforms that enable rapid design, expression, and scalable production of complex proteins for biopharmaceuticals, industrial biotechnology, and agriculture.

Founders & leadership· Y Combinator alumni (W23)

PG

Patrick GrossmanninFounder

KV

Kilian VogeleinFounder

Investors · 2

Y

Y CombinatorSan Francisco · $500K

10

10x FoundersreportedMünchen · $270K – $2.7M